SPONSOR
Alessandro Doria
Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1Heart Failure
Alessandro Doria is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1, Heart Failure.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Alessandro Doria
How many clinical trials has Alessandro Doria sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Alessandro Doria, of which 1 are actively recruiting participants. These trials cover conditions including Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Alessandro Doria research focus on?
Alessandro Doria clinical trials span Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1, Heart Failure. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Alessandro Doria clinical trial?
To participate in a Alessandro Doria trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Alessandro Doria trials with current recruitment status updated daily.
Clinical Trials by Alessandro Doria
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology